Automated Insulin Delivery

Where the papers sit

11 papers from the last 6 months study Automated Insulin Delivery directly · updated from PubMed 1 Nov 2026

• AID in Diverse Diabetes Care

  AID is being tested across settings where standard glucose management is difficult, including advanced chronic kidney disease and cystic-fibrosis-related diabetes. Other work follows device adoption, discontinuation, acute-care use, and diabetes distress in adults with type 1 diabetes. Comparisons with non-users and mixed-methods accounts broaden the endpoints beyond glucose metrics. The shared direction is implementation in diverse populations, while clinical advantages and barriers remain context-dependent.

  5 papers · 45.5%

• Real-World Glycemic Control

  Time-in-range is the central outcome, with attention to time below range, hemoglobin A1c, and safety across routine care. Adaptive tubeless systems and open-source AID are evaluated in children and across age groups, while Control-IQ studies test how meal composition alters postprandial control. Menstrual-cycle changes in insulin requirements highlight the need for context-sensitive settings. The work favors real-world personalization rather than a single universal algorithm.

  4 papers · 36.4%

• Youth AID Adoption and Outcomes

  Predicting who benefits after AID initiation is the main focus, using glycemic trajectories, hemoglobin A1c, and logistic models. Youth studies seek clinical features that distinguish improving from less-improving trajectories. Multicenter data in preschool children extend AID evaluation to early use, where safety and feasibility remain central. The evidence supports risk-stratified counseling, but does not establish a single predictor of success.

  2 papers · 18.2%